Previous Article | Next Article 
J Virol, May 1998, p. 4057-4064, Vol. 72, No. 5
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Retrotransposition of Nonviral RNAs in an Avian
Packaging Cell Line
Richard
Lum and
Maxine L.
Linial*
Division of Basic Sciences, Fred Hutchinson
Cancer Research Center, Seattle, Washington 98104
Received 22 October 1997/Accepted 20 January 1998
 |
ABSTRACT |
Retroviruses produced from the quail packaging cell line SE21Q1b
predominantly contain cellular RNAs instead of viral RNAs. These RNAs
can be reverse transcribed and integrated into the genomes of newly
infected cells and are thereafter referred to as newly formed
retrogenes. We investigated whether retrogene formation can occur
within SE21Q1b cells themselves and whether this occurs intracellularly
or via extracellular reinfection. By using packaging cell line mutants
derived from the SE21Q1b provirus and selectable reporter constructs,
we found that the process requires envelope glycoproteins and a
retroviral packaging signal. Our results suggest that extracellular
reinfection is the primary route of retrotransposition of nonviral
RNAs.
 |
INTRODUCTION |
Mobile genetic elements play a
significant role in shaping eukaryotic genomes (4). These
elements may provide a genome with plasticity for adapting to a
changing environment. Mobile elements that transpose via an RNA
intermediate require reverse transcription and are called
retrotransposons. Retrotransposons are divided into viral (long
terminal repeat [LTR]) and nonviral (non-LTR) families
(35). The former family encompasses retroviruses, mammalian
intracisternal A-type particles, Ty elements in Saccharomyces cerevisiae, and copia in Drosophila melanogaster.
Non-LTR retrotransposons include short and long interspersed nuclear
elements. Processed pseudogenes are cDNA copies of cellular RNAs and
are most likely the end products of aberrant retrotransposition.
Processed pseudogenes contain many features which are consistent with
this idea, such as the absence of 5' promoter elements, the loss of
introns, and the presence of remnants of a polyadenosine tail. Direct
nucleotide repeats are often found flanking processed pseudogenes,
which may reflect a formation mechanism similar to that of retroviruses and other retrotransposons (15, 34). However, processed
pseudogene formation is not likely to be the end product of
extracellular retroviral infection since retrogenes lack some of the
features of processed pseudogenes (7, 17).
We asked whether retroviruses could mediate retrogene formation by an
intracellular pathway. For these studies, we devised a system based on
the SE21Q1b quail packaging cell line which contains a single Rous
sarcoma virus provirus with a deletion in the packaging (
) region
(1, 2). Viruses produced from these cells lack viral genomes
but contain cellular RNAs which are capable of being transduced as
integrated cDNAs by retrofection (Fig. 1,
pathway A) (18).

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 1.
Schematic diagram representing the possible viral
pathways for retrofection and autoretrofection. The SE21Q1b packaging
cell line has a deletion in the viral RNA packaging signal ( ).
Virions that are produced contain cellular RNAs which are transduced as
cDNAs to quail QT35 cells by a process called retrofection (pathway A).
Autoretrofection leads to the formation of cDNAs in SE21Q1b cells.
Autoretrofection may occur via a pathway involving intracellular
particles (pathway B) or by extracellular reinfection of SE21Q1b cells
(pathway C).
|
|
We also noted that cDNA copies of a marker RNA could be found in this
packaging cell line (18a). We have named this process autoretrofection, which may occur intracellularly or through
extracellular reinfection (Fig. 1, pathways B and C). An internal
pathway is a plausible hypothesis, because extracellular reinfection is
usually prevented by viral interference (36). Heidmann et
al. have also described an intracellular retrotransposition pathway
used by retroviruses (14, 30). To determine the pathway of
autoretrofection, we established packaging cell lines that provide the
viral proteins in trans but that are deficient in viral
envelope glycoproteins and we developed reporter genes to interact in
cis with the viral proteins in order to detect
retrotransposition events. By using a genetic selection scheme, we
could not find evidence for an intracellular pathway for
autoretrofection. However, we found that cellular RNAs that contain a
packaging sequence undergo autoretrofection via extracellular
reinfection.
 |
MATERIALS AND METHODS |
Recombinant proviruses and packaging cell lines.
pSEenv+ and pSEenv
are recombinant proviral
molecular constructs derived from the SE21Q1b proviral molecular clone.
The SE21Q1b proviral molecular clone, pSE21Q1b, has been previously
described (1). pSEenv+ was constructed by
replacing the pSE21Q1b KpnI-MluI fragment with a
2.2-kb fragment from pRCASBP (23). A hygromycin phosphotransferase-encoding gene (hph) was added to enable selection. A
1.3-kbp hph gene was removed from pBStHyg by SalI and
SpeI digestion (12). ClaI linkers were
attached and the 1.3-kb fragment was ligated to the ClaI
site in the 2.2-kb KpnI-MluI fragment.
pSEenv
was constructed by replacing the pSE21Q1b
KpnI-MluI fragment with a fragment containing a
deletion in the envelope. An 800-bp XbaI-NcoI fragment was removed from the KpnI-MluI fragment
to create an out-of-frame env deletion.
pSEenv+pol
.1 and -.2 were constructed by
digesting pSEenv+, which has a restriction site in
pol, with HpaI, followed by Bal31
exonuclease digestion and blunt-end ligation. Proviral molecular clones
were sequenced to identify deletions. Clone 1 contains a 20-bp deletion
(starting at position 2720 of avian leukosis virus [ALV]; GenBank
accession no. M37980), and clone 2 has a 31-bp deletion (starting at
position 2723 of ALV). Both pol mutants lead to frameshifts
that are predicted to result in premature termination. Mass cultures of
packaging cells were established by transfecting the viral constructs
into quail QT35 cells and selecting colonies that were resistant to 100 µg of hygromycin/ml (3). Packaging cells were named
QTSEenv+, QTSEenv
, and
QTSEenv+pol
.1 and -.2.
Construction of selectable reporter genes, transfection,
autoretrofection assay, and coculture.
To create the
retrotransposition reporter construct p611, a 2.8-kb
HindIII-NotI DNA cassette encoding a
cytomegalovirus immediate-early (CMVie) promoter-reverse-oriented
intron-phleomycin resistance gene was inserted into the unique
SmaI site in pRSVneo (11) between neo
and the simian virus 40 polyadenylation signal. This cassette is
designed to allow phleomycin selection only after reverse transcription
and integration of spliced RNAs transcribed from the LTR promoter,
because a polyadenylation signal in the intron prevents the formation
of readthrough transcripts from the CMVie promoter.
p

+611 was constructed by replacing the LTR promoter of p611 with the
LTR, primer binding site (PBS), and

-containing sequence
from LA611,
an ALV vector containing the phleomycin cassette (
13).
Both
p611 and LA611 were digested with
ScaI and
NheI,
and a 4-kb
fragment from p611 was ligated to a 5-kb fragment from LA611
to
construct p

+611.
QT35 cells, SE21Q1b cells, and the quail packaging cell lines
QTSE
env+, QTSE
env
, and
QTSE
env+
pol
were transfected with p611
or
p

+611, and mass cultures were selected in 150 µg of G418/ml.
These cell lines were named QT611, QT

+611, SE611,
QT611SE
env+,
QT

+611SE
env+,
QT611SE
env
, QT

+611SE
env
,
QT

+611SE
env+
pol
.1,
and
QT

+611SE
env+
pol
.2. Mass
cultures were expanded, and 3 ×
10
6 to 4 × 10
6 cells were seeded on 10-cm-diameter tissue culture
plates. Autoretrofection
was assayed by treating packaging cells that
harbor the selectable
phleomycin reporter constructs with 15 µg of
phleomycin/ml.
QT35 cells and QTSE
env+ packaging cells were transfected
with the plasmid pBabe (
22), which confers puromycin
resistance
(Pur
r), to establish QTBabe and
QTSE
env+Babe cells. Cocultures were
established by plating
equal numbers of packaging cells containing
the phleomycin-selectable
reporter construct with puromycin-resistant
cells. Cocultures were
treated with 15 µg of phleomycin/ml and
1 µg of puromycin/ml to
select phleomycin-resistant (Phl
r) and Pur
r
clones.
Genomic DNA preparations.
Cells were trypsinized and
collected by centrifugation. Pelleted cells were lysed in a solution
containing 0.3 M NaCl, 5 mM EDTA, 10 mM Tris-Cl (pH 7.4), 0.5% sodium
dodecyl sulfate, and 200 µg of proteinase K/ml for 2 h at
55°C. DNAs were extracted with phenol-CHCl3, followed by
isopropanol precipitation at 4°C overnight. DNAs were digested with
ClaI and 100 µg of RNase/ml, adjusted to 15 mM EDTA plus
50 mM NaOH, incubated at 65°C for 1 h, neutralized with 5 M
NH4 acetate (pH 7.4), and ethanol precipitated overnight.
Southern blot analysis and hybridizations.
Genomic DNAs (15 µg) were digested with the restriction enzymes ApaI and
NsiI, and then the DNAs were electrophoresed on 1% agarose
gel. The DNAs in the gel were transferred to a GeneScreen (NEN, Boston,
Mass.) hybridization transfer membrane by alkaline transfer
(21) and hybridized with 32P-labeled DNA probes.
Hybridizations were performed in Stark's buffer, which consists of 5×
SSC (0.75 M NaCl, 75 mM Na3 citrate [pH 7.0]), 25 mM
Na2HPO4, 0.02% bovine serum albumin, 0.02%
Ficoll, 0.02% polyvinylpyrrolidone, 250 µg of salmon sperm DNA/ml,
and 50% formamide plus 10% dextran sulfate at 42°C with
106 cpm of probe/ml. Filters were washed in 0.2× SSC at
65°C and exposed to X-ray film at
80°C. Both a 1.4-kb DNA
fragment spanning the CMVie promoter and phleomycin gene and an
EcoNI-XhoI 500-bp DNA intron fragment from
p
+611 were used as probes after 32P random-primed DNA
labeling (Boehringer Mannheim, Indianapolis, Ind.). Prior to
hybridization with the 32P-labeled 500-bp probe, the
32P-labeled 1.4-kb probe was removed from the Southern blot
by incubating the blot three times in 10 mM Tris-Cl (pH 8.0), 1 mM
EDTA, and 0.1% sodium dodecyl sulfate for 10 min at 90°C.
Nested PCR.
Nested PCR analysis (see Fig. 2B, bottom) for
the detection of the retrotransposed reporter gene was performed as
follows. Total cellular DNAs (200 ng) were used in nested PCRs. The
first-round PCR mixture consisted of 10 mM Tris-Cl (pH 8.3), 50 mM KCl,
2 mM MgCl2, 50 µg of gelatin/ml, 0.1 mM deoxynucleoside
triphosphates, 1 U of AmpliqTaq (Perkin-Elmer, Branchburg, N.J.), 100 ng of PH2 primer (5'GCCGGTCGGTCCAGAACTCG3'), and 100 ng of
CMV1 primer (5'CCAAAATGTCGTAACAACTCCGC3') in 75 µl. Hot
start with paraffin wax was initiated by preincubating the reaction mix
at 95°C for 5 min, and then the mixture was thermocycled at 94°C
for 1 min, at 66°C for 1 min, and 72°C for 2 min for 30 cycles. The
second-round PCR consisted of adding 2 µl of the initial PCR mixture
to the above-described reaction mix after replacing the primers with
the internal primers PH1 (5'GAGCACCGGAACGGCACTGG3') and CMV2
(5'GGCGGTAGGCGTGTACGGTG3'). CMV2 (2 × 105
cpm) at >107 cpm/µg was included in a 75-µl reaction
mixture overlaid with mineral oil. CMV2 was 32P end labeled
by polynucleotide kinase and [
-32P]ATP and then passed
through a G-50 Sephadex column to rid it of unincorporated
radionucleotides. Thermocycle incubation was carried out as described
above for the first round except the 72°C step was 1.5 min and there
were only 25 cycles.
QC-PCR.
Quantitative competitive PCR (QC-PCR) was performed
on genomic DNAs that were digested with ClaI and RNase A and
then incubated in 50 mM NaOH at 65°C for 1 h, neutralized with
an equal volume of 5 M NH4 acetate, and precipitated with
ethanol. Precipitates were collected by centrifugation, and the
concentration was determined spectrophotometrically. A 218-bp PCR
fragment containing the sequences for primers PH1 and CMV2 at the ends
was used as a competitive template. The 218-bp fragment was purified
through low-melting-point agarose, quantified spectrophotometrically,
and diluted with 50 µg of glycogen/ml to prevent DNA loss due to
adsorption to tube walls. PCR was carried out with 200 ng of genomic
DNA with various amounts of 218-bp competitor DNA. The PCR mixture
consisted of 10 mM Tris-Cl (pH 8.3), 50 mM KCl, 2 mM MgCl2,
50 µg of gelatin/ml, 0.1 mM deoxynucleoside triphosphates, 1 U of
AmpliqTaq (Perkin-Elmer), and 100 ng each of primers PH1
(5'GAGCACCGGAACGGCACTGG3') and CMV2
(5'GGCGGTAGGCGTGTACGGTG3'). CMV2 (2 × 105
cpm) at >107 cpm/µg was included in a 75-µl reaction
mixture overlaid with mineral oil. CMV2 was 32P end labeled
with [
-32P]ATP and polynucleotide kinase and then
passed through a G-50 Sephadex column to rid it of unincorporated
radionucleotides. Thermocycle incubation was carried out by
preincubating the reaction mixture at 95°C for 5 min and then
thermocycling it at 94°C for 1 min, at 66°C for 1 min, and at
72°C for 2 min for 30 cycles.
 |
RESULTS |
Construction of a selectable reporter gene to study
autoretrofection.
Figure 1 diagrams two possible autoretrofection
pathways (B and C). One pathway is by an intracellular route (B), and
the other is via extracellular reinfection (C). Packaging cell lines were derived from SE21Q1b proviral mutants that lack
and that either contain the envelope gene (env+) or lack a functional
envelope gene (env
). In the absence of envelope
glycoproteins, the intracellular route is predicted to be the
predominant one.
The selectable reporter constructs p611 and p

+611 were used to
identify cells which are capable of autoretrofection. Figure
2 shows the selectable reporter
constructs p611 (Fig.
2A) and
p

+611 (Fig.
2B). p

+611 has a
complete LTR, PBS, and the packaging
sequence,

. In both constructs
Phl
r is conferred if the intron is removed. The expected
pathway leading
to Phl
r is diagrammed for p

+611 (Fig.
2B); a phleomycin resistance retrogene
is formed after splicing of the
RNAs, reverse transcription, and
integration of cDNAs. The
polyadenylation site in the intron prevents
readthrough
transcripts from the CMVie promoter, which encodes
phleomycin
resistance.

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 2.
Selectable reporter constructs. p611 (A) and p +611
(B) are designed to express a reporter retrogene after
retrotransposition. The formation of the reporter retrogene is shown
only for p +611. The first large downward-pointing arrow indicates
the transcribed and spliced RNA. Splicing out the intron removes a
polyadenylation signal. After reverse transcription and integration,
the second large downward-pointing arrow shows the formation of the
spliced retrogene which expresses the phleomycin resistance gene from
the CMVie promoter. The U3, U5, and R regions of the ALV LTR promoter
are indicated. The LTR of p611 contains a deletion in U5. neo, neomycin
phosphotransferase gene; phleo, phleomycin resistance gene; 1-kb
intron, second intron of the chicken c-myc gene
reconstructed to contain a modified -globin polyadenylation signal
in the opposite orientation; pA site, polyadenylation site; pbs, PBS.
The 5' splice donor (SD) and 3' splice acceptor (SA) sites are
indicated by small open downward-pointing arrows. ApaI and
NsiI restriction sites are indicated with the restriction
fragment length of 2.4 kb for both reporters and 1.4 kb for the
retrogene. Horizontal arrows above the LTRs and the CMVie promoter
indicate the directions of transcription from the respective promoters.
"CMVie," "pA site," and "phleo" are printed backwards to
designate their opposite strand orientation. PH2 and CMV1 and PH1 and
CMV2 are nested PCR primer pairs (small horizontal arrows). A
233-bp PCR fragment that is diagnostic for the spliced retrogene is
produced from the internal primer pairs PH1 and CMV2.
|
|
Env+ packaging cells are not capable of
autoretrofection with RNAs lacking
but form unusual episomal
retrogenes.
In order to test whether cellular RNAs can undergo
autoretrofection, p611 was transfected into SE21Q1b cells and QT35
cells. After selection in G418, SE21Q1b-derived SE611 and QT35-derived QT611 cells were obtained and expanded into mass cultures which were
treated with phleomycin. As presented in Table
1, approximately three SE611
Phlr clones were obtained per 6 × 106
cells. This frequency is 10 times greater than that obtained with
nonvirus-producing QT611 cells.
PCR was performed on some of these clones and mass cultures with
primers that flank the splice junction (Fig.
2B, bottom),
and this
occasionally resulted in a 233-bp product indicative
of a spliced
retrogene (Fig.
3, lanes 2, 3, and 6).
Sequence analysis
of this product showed that the splice junction was
correctly
formed, thus providing evidence that an RNA intermediate was
involved
in the creation of a new retrogene. However, only 2 of 15 SE611
Phl
r clones produced the 233-bp PCR product (Table
1)
while the majority
of clones did not produce a PCR product or generated
a product
of another size (Fig.
3, lanes 4 and 5).

View larger version (45K):
[in this window]
[in a new window]
|
FIG. 3.
PCR products from SE611 Phlr cells. Lane 1 contains 32P-labeled pBR322-MspI DNA markers.
Lanes 2 to 13 show PCR products with primers PH1 and CMV2, and lanes 2 to 4 show products obtained when DNAs from three SE611 Phlr
clones were used as templates. Lanes 5 and 6 contain DNAs from two
SE611 Phlr mass cultures, lane 7 contains PCR products from
cDNAs synthesized from viral RNAs obtained from SE611 virus, lane 8 contains no genomic DNA, and lane 9 contains p611. The filled arrow
indicates the 1.2-kb product from the intron-containing unspliced DNA,
and the open arrow indicates the 233-bp product from the intron-minus
spliced DNA. Molecular weights are noted at the left.
|
|
Southern blot analysis was performed on the genomic DNAs extracted from
the SE611 Phl
r clones to see whether integrated copies of
the predicted retrogene
were formed. Unexpectedly, we found that it was
not possible to
detect a restriction fragment corresponding to the
expected retrogene
(data not shown). To analyze the source of the
233-bp PCR products
further, we used QC-PCR to determine the number of
retrogene copies
per genome (
24). Quantitation is based on
the ability of the
competitor template to be amplified to the same
extent as the
target template when both are present in equal amounts.
Figure
4, lanes 10 to 16, shows the
results of QC-PCR when genomic DNA
containing a single copy of the
retrogene is used with the competitor.
The equivalence point
corresponds to approximately 6.25 × 10
4 copies per
200 ng of genomic DNA. This value agrees well with
the calculated
number of 8.7 × 10
4 copies of a single-copy sequence
present in 200 ng of chicken
fibroblast DNA with one genomic equivalent
of 2.3 pg (
26). Lanes
3 to 9 show the results from a SE611
Phl
r clone which was positive in the PCR assay. This DNA
reaches equivalence
between 1.25 × 10
3 and 6.25 × 10
2 copies of the competitor. Hence, the retrogene in
the SE611 Phl
r clone is present in only about 1 to 2% of
the cells. We have
further found that the retrogene in the SE611
Phl
r clone is enriched in the low-molecular-weight fraction
of Hirt
supernatants and in the cytoplasmic fraction of the cellular
extract
(data not shown). These results suggest that the retrogene is
present as unintegrated episomal DNAs that may be localized in
a
cytoplasmic compartment. Since these retrogenes are not integrated,
autoretrofection does not occur in SE21Q1b cells when they are
assayed
with p611.

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 4.
QC-PCR was used to measure retrogene copy numbers. Lane
1, 32P-labeled pBR322-MspI DNA markers; lane 2, 233-bp spliced PCR product; lanes 3 to 9, SE611 Phlr clone;
lanes 10 to 16, QT35 Phlr retrofectant clone; lanes 3 to 9, 1 × 104 to 1.5 × 102 copies of a
218-bp competitor DNA; lanes 10 to 16, 1 × 106 to
1.5 × 104 copies of the competitor DNA. The position
of the 233-bp PCR product from the intron-minus spliced DNA is
indicated by the open arrow, and that of the 218-bp competitor is
indicated by the closed arrow. Molecular weights are noted at the
left.
|
|
Env-deficient packaging cells are not capable of
autoretrofection.
Experiments with the envelope-deficient
packaging cells were performed as described above in order to test
whether autoretrofection occurs intracellularly. Before testing the
envelope-deficient packaging cells for autoretrofection with p611, it
was necessary to see whether the envelope-producing packaging cells
established by transfecting QT35 cells with pSEenv+ could
recapitulate the results with SE21Q1b cells. As shown in Table 1,
QT611SEenv+ cells are able to generate Phlr
cells at about the same frequency as SE611 cells. Furthermore, when
pooled colonies of Phlr cells were analyzed by PCR, it was
possible to detect the correctly spliced 233-bp PCR fragment (Fig.
5, lanes 9 to 11).

View larger version (82K):
[in this window]
[in a new window]
|
FIG. 5.
PCR products from QT611SEenv+
Phlr and QT611SEenv Phlr cells.
Lane 1 contains 32P-labeled pBR322-MspI DNA
marker fragments. Lanes 2, 3, 6, and 7 contain four different
QTSEenv Phlr mass cultures, and lanes 4, 5, and 8 contain three different QTSEenv Phlr
clones. Lanes 9, 10, and 11 contain cells from three different
QT611SEenv+ Phlr mass cultures. Lane 12 contains
cDNAs synthesized from SE611 virus, lane 13 contains no genomic DNA,
and lane 14 contains p611. The filled arrow points to the
1.2-kb-intron-containing DNA, and the open arrow points to the
233-bp-intron-minus DNA product. Molecular weights are noted at the
left.
|
|
The envelope-deficient packaging cells, QT611SE
env
,
produced a two- to threefold-lower frequency of Phl
r cells
than its
env+ counterpart (Table
1). However, this
difference
is unlikely to be significant since the total number of
Phl
r cells from both packaging lines was very low. PCR
analysis of
these Phl
r cells did not reveal the correct
233-bp fragment. Instead, aberrant
fragments of different sizes or no
products other than the unspliced
fragment were detected (Fig.
5, lanes
2 to 8). It has not been
possible to find any QT611SE
env
Phl
r cells that create a correctly spliced retrogene;
hence, there
is no evidence that autoretrofection occurs in these cells
with
the p611 reporter construct. There is a faint PCR fragment of
approximately the correct size in lane 2. Sequence analysis of
this
band and other PCR products with aberrant sizes showed that
they
contained deletions of the intron and were not properly spliced
(data
not shown).
Autoretrofection of
-containing RNAs occurs in
envelope-expressing packaging cells.
Since autoretrofection did
not occur with p611, increasing the likelihood of the event was
possible by increasing the packaging efficiency of the reporter RNA.
Hence, a derivative of p611, p
+611, which contains a
sequence as
well as the PBS used for minus-strand DNA synthesis was constructed.
When p
+611 was assayed for autoretrofection in an envelope-producing
packaging cell line (QT
+611SEenv+), there was an increase
in the number of Phlr cells during culture. As seen
graphically in Fig. 6, the number of
Phlr cells increased from approximately 50 to 500 per
6 × 106 cells during weeks 3 to 5. This is a 100-fold
increase in the number of Phlr cells compared to that when
p611 was used (compare to data in Table 1). The low frequencies of
generating Phlr cells in QT
+611 cells and QT611 cells as
well as in packaging cells harboring p611 did not change during
continuous culture.

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 6.
Graph of the numbers of phleomycin-resistant cells
assayed after time in culture. The number of Phlr cells per
6 × 106 cells is plotted against the duration of
culture in weeks. Open squares, QT +611SEenv+ cells;
shaded diamonds, QT +611Senv- cells; solid triangles,
QT +611 cells and QT +611SEenv+pol- cells.
|
|
PCR analysis of 10 QT

+611SE
env+ Phl
r clones
showed the correctly spliced 233-bp fragment (Fig.
7, lanes 2 to 11), indicating
that
retrogenes were being formed in these cells. Southern blot
analysis of
genomic DNAs isolated from these QT

+611SE
env+
Phl
r clones was performed to determine if integrated
retrogenes were
formed. Restriction enzyme digestion of p

+611 with
ApaI and
NsiI
results in a 2.4-kb fragment (Fig.
2B). This same fragment was
expected on the Southern blot when p

+611
was hybridized with
a 1.4-kb probe containing CMVie and phleomycin gene
sequences.
If a retrogene is present, a 1.4-kb fragment was predicted
to
be formed after removal of the 1-kb intron by splicing.
Surprisingly,
the Southern blot showed that only 5 of the 10 clones
contained
the 2.4-kb
ApaI-
NsiI restriction
fragment (Fig.
8, lanes 5, 8,
9, 11, and
12). The 1.4-kb spliced fragment which is indicative
of an integrated
newly formed retrogene is present in 9 of the
10 clones. In Fig.
8,
lane 5, the DNA from this clone shows a
strong hybridizing signal for
the 2.4-kb fragment but no signal
for the 1.4-kb fragment. Since this
clone was PCR positive, we
cannot preclude that this Phl
r
clone arose by a mechanism similar to that observed during our
p611
autoretrofection assays. The absence of the 2.4-kb p

+611
restriction
fragment and the presence of the spliced retrogene
in some of the
clones (Fig.
8, lanes 3, 4, 6, 7, and 10) are likely
to be the result
of retrofection during the initial selection
in G418 cells after
transfection of the packaging cells with p

+611.
That is, virus from
QT

+611SE
env+ cells (which arose after transfection
of
QTSE
env+ cells with p

+611) infected QTSE
env+
cells lacking
the p

+611 construct. Only 4 of the 10 clones show both
the 2.4-kb
and 1.4-kb fragments. The first five clones (Fig.
8, lanes 3 to
7) were isolated at 3 weeks, and the next five clones (Fig.
8,
lanes
8 to 12) were isolated at 5 weeks. As indicated in Fig.
8, four of the
five week 5 clones have the 2.4-kb fragment whereas
only one of the
five week 3 clones has this fragment. This result
is likely to be an
indication that retrofection of QTSE
env+ cells
occurred
early during G418 selsection and that autoretrofection
of
QT

SE
env+ cells predominated during continuous culture. In
regard to the 10 clones analyzed, autoretrofection occurs in
approximately
40% of the Phl
r cells. In order to confirm
that the 1.4-kb
ApaI-
NsiI fragment
does not
contain the intron, the Southern blot was stripped of
the first probe
and rehybridized with a 500-bp intron probe. As
shown in Fig.
9, the 1.4-kb fragment does not hybridize
to the
intron probe whereas the 2.4-kb fragment continues to do so. By
comparing Fig.
9 to Fig.
8, it is also possible to identify six
other
fragments of different sizes that do not hybridize to the
intron probe.
Two of these fragments are smaller than the 1.4-kb
fragment and, hence,
most likely have lost additional sequences
along with the intron
between the restriction enzyme sites. The
other four are larger and may
therefore be partial restriction
enzyme digestion products or
retrogenes that were formed with
errors such that
ApaI
and
NsiI sites outside the expected retrogene
define their
fragment lengths.

View larger version (88K):
[in this window]
[in a new window]
|
FIG. 7.
PCR products from QT +611SEenv+
Phlr clones. Lanes 1 and 15, 32P-labeled
pBR322-MspI DNA marker fragments; lanes 2 to 11, DNA from 10 QT +611SEenv+ Phlr clones; lane 12, no genomic
DNA; lane 13, p +611; lane 14, cDNAs synthesized from SE611 virus.
The filled arrow indicates the position of the 1.2-kb-intron-containing
DNA fragment, and the open arrow indicates the position of the
233-bp-intron-minus fragment. Molecular weights are noted at the
left.
|
|

View larger version (76K):
[in this window]
[in a new window]
|
FIG. 8.
Southern blot of QT +611SEenv+
Phlr clones. Genomic DNAs were digested with the
restriction enzymes ApaI and NsiI and hybridized
to a 32P-labeled 1.4-kb DNA fragment containing both the
CMVie promoter and phleomycin-resistant gene sequences. Lanes 1 and 15, 32P-labeled lambda- HindIII
marker DNA; lane 2, QT35 DNA; lanes 3 to 12, DNAs from 10 QT +611SEenv+ Phlr clones which were used in
the PCR experiments shown in Fig. 7; lane 13, DNA from a
Phlr Purr clone obtained by coculturing
QT +611SEenv+ cells with QTBabe cells; lane 14, 40 pg of
p +611. The filled arrow indicates the
2.4-kb-unspliced-intron-containing fragment, and the open arrow
indicates the 1.4-kb-intron-minus retrogene fragment. The six fragments
that are marked with asterisks and the 1.4-kb fragments do not
hybridize to the 500-bp intron probe. Molecular weights (in thousands)
are noted at the left.
|
|

View larger version (78K):
[in this window]
[in a new window]
|
FIG. 9.
Rehybridized Southern blot of QT +611SEenv+
Phlr clones. The Southern blot shown in Fig. 8 was stripped
from the 32P-labeled 1.4-kb DNA fragment containing both
the CMVie promoter and phleomycin-resistant gene sequences, and the
blot was rehybridized to a 32P-labeled 500-bp intron
fragment from p +611. The filled arrow indicates the
2.4-kb-unspliced-intron-containing fragment. The 9-kb fragment seen in
lane 2 (quail QT35 DNA) is present in lanes 3 to 13 and is the
c-myc intron in quail cells which cross-hybridizes to the
chicken c-myc intron probe from p +611. Molecular weights
(in thousands) are noted at the left.
|
|
The p

+611 construct was also tested in envelope-deficient
QTSE
env
packaging cells. However, this did not increase
the number
of Phl
r cells above the background level after 5 weeks of culture (Fig.
6). There was an increase to approximately 50 Phl
r cells per 6 × 10
6 cells after 7 to 9 weeks in culture. However, PCR analysis of
these cells failed to
produce the 233-bp PCR fragment containing
the correctly spliced
junction of the reporter construct (data
not shown). This result
indicates that autoretrofection does not
occur in the absence of viral
envelope and is consistent with
a model in which autoretrofection
occurs by way of extracellular
reinfection.
We also assayed for the occurrence of autoretrofection in
QT

+611SE
env+
pol
cells to determine whether
Pol is required. Two
pol-defective packaging cells that
express envelope were each
established with proviral constructs with
two different
pol deletions.
Both
QT

+611SE
env+
pol
.1 and -.2 supernatants
tested negative
for reverse transcriptase activity (data not shown).
When both
pol mutants were treated with phleomycin, there
was no increase
in the number of Phl
r cells above that seen
with QT

+611 (Fig.
6). Thus, autoretrofection
is dependent on active
reverse transcription.
Autoretrofection is not blocked by viral interference.
Since
autoretrofection occurred only in the presence of envelope, it likely
occurs by extracellular reinfection. However, viral interference
usually prevents superinfection of virus-producing cells. Therefore, it
was important to know whether autoretrofection occurred because there
was incomplete blockage to viral superinfection. In order to assess
whether blockage to superinfection was incomplete, QT
+611SEenv+ cells were cocultured with either QTBabe or
QTSEenv+Babe cells. QTBabe cells are QT35 cells which
have been transfected with the plasmid pBabe to confer puromycin
resistance. Likewise, QTSEenv+ packaging cells were
transfected with the same plasmid to establish puromycin-resistant
QTSEenv+Babe cells. Both puromycin-resistant cell lines were
used as marked cells in coculture experiments to test whether
viral-envelope-expressing packaging cells were resistant to virus
superinfection. Because these cells are puromycin resistant, viral
interference can be determined by comparing the number of phleomycin-
and puromycin-resistant (Phlr Purr) colonies
that arises in each of the cocultures with QT
+611SEenv+ cells. Virus produced from QT
+611SEenv+ cells can infect
QTBabe cells and transduce phleomycin resistance (data not shown).
However, QTSEenv+Babe cells produce the same subgroup A
envelope glycoprotein and are infected only if there is incomplete
resistance to superinfection. Table 2
shows that there is only a 10-fold reduction in the number of
Phlr Purr colonies when both cells in coculture
produce virus. The frequency of phleomycin resistance in the presence
of envelope glycoproteins is approximately 10
5 contrasted
to that of 10
4 in envelope-minus cells. There is an
increase in the total number of Phlr Purr cells
as the coculture is passaged over time. However, there is only a
threefold reduction of Phlr Purr cells between
the QTBabe and QTSEenv+Babe cocultured cells after 2 weeks,
indicating that viral interference is not complete and that the
env+ cells are infected fairly efficiently. Filtered virus
also gave only about a 10-fold reduction in titer on the env+ cells (data not shown).
 |
DISCUSSION |
We initiated these studies to test whether autoretrofection occurs
via an intracellular pathway or via extracellular reinfection. Our
results show that autoretrofection occurs via extracellular reinfection
despite the presence of envelope glycoproteins that are expected to
prevent superinfection. This extracellular reinfection is unusual,
because highly efficient viral interference is most commonly seen with
ALVs (32, 33, 36). However, lack of complete viral
interference has also been noted (37). It is possible that
the lack of interference is more pronounced in the continuous cell
lines we used rather than in primary cultures. In our experiments to
determine the level of resistance to superinfection, we used cell
cocultures rather than cells infected with viral supernatants because
the former most closely resemble our autoretrofection system. We
therefore cannot exclude the possibility that cell-to-cell interactions
in our cocultures also played a role in generating doubly resistant
cells. However, we also saw low levels of interference using filtered
virus.
Our genetic selection for autoretrofection was designed to allow for
detection of newly formed retrogenes. However, the results show that
there is a background level of Phlr cells which arise
independently of autoretrofection. The genetic selection allows
detection only of bona fide retrogenes when there are greater than 10 Phlr colonies per million cells plated. When colonies form
below this frequency, our biochemical analysis of these cells shows
that they do not contain correctly spliced integrated retrogenes or contain correctly spliced episomal retrogenes. While episomes can be
transcriptionally active (29), the absence of the retrogene in every cell calls into question its significance in conferring drug
resistance. These Phlr cells survive in continuous culture
in the presence of phleomycin, and hence, the majority of the cells are
resistant to the drug even in the absence of a spliced retrogene. We
suspect that readthrough transcripts from the CMVie promoter lead
to this background level of Phlr cells, because RNase
protection assays from some of these cells show readthrough transcripts
in greater abundance than transcripts from a spliced retrogene (data
not shown). Thus, the intronic polyadenylation signal might not be used
in all cells, permitting ribosomes to successfully scan the 1-kb intron
even in the presence of multiple termination codons.
We were able to detect autoretrofection only in packaging cells that
express viral envelope glycoproteins in the presence of
- and
PBS-containing reporter RNAs. This is not unexpected, because the
packaging sequence increases the number of viral particles containing
the reporter RNA (8) and the PBS aids in reverse transcription. A curious aspect is that in our initial experiments, autoretrofection in SE21Q1b cells, as mentioned in the introduction, occurred with a marked RNA which did not contain
or the PBS. Since
these cells were passed extensively for some time (over years), we
surmise that autoretrofection can occur without viral cis
sequences, albeit at a much lower frequency than with cis sequences.
Heidmann et al. have shown that in the absence of viral glycoproteins,
mammalian retroviruses can retrotranspose through an intracellular
pathway (14, 30). These investigators also reported that
viral RNAs with
sequences spliced out can be used more efficiently
for retrotransposition than viral RNAs containing
in the absence of
viral proteins and that processed pseudogene formation can be detected
in HeLa cells (20, 31). They propose that these events are
not virus mediated but are due to long interspersed nuclear elements or
to some endogenous cellular sources of reverse transcriptase acting
upon their marked RNAs. Our results with a reporter construct
containing the 5' LTR, PBS, and
show that these cis
sequences are not adequate for supporting the intracellular pathway.
This pathway may require other cis sequences such as the
polypurine tract and the 3' LTR to ensure completion of cDNA synthesis
and the generation of cDNA ends competent for integration. Our results
show that cellular RNAs are rarely able to undergo intracellular
retrotransposition even in the presence of retroviruses in avian cells.
However, our observation of the lack of retrotransposition of cellular
RNAs in quail cells may be significant in that processed pseudogenes
are rare in avian cells compared to their frequency in mammalian cells
(10, 25, 35). Avian cells may lack retroelements which are
actively involved in processed pseudogene formation.
The intracellular pathway that we studied is probably inefficient,
because Gag and Pol proteins are not yet in their mature forms. It is
generally thought that viral proteins require protease processing, and
this processing is accomplished only by activated protease soon after
budding (6, 16). For example, there is only minimal reverse
transcriptase activity without protease processing and viruses
defective in protease are not infectious (5, 27, 28). It may
be necessary for the Gag polyprotein to be cleaved to form an active
integration complex. Hence, mature integration-competent intracellular
particles would be rare even if there were some intracellular protease
activation. Even though the viral trans-acting proteins may
not be fully active in the intracellular pathway due to inactive
protease, the findings of Heidmann et al. which show that viral RNAs
are able to use this pathway suggest that the cis sequences
play a larger role in determining intracellular retrotransposition than
the trans-acting proteins.
Curiously, we detected correctly spliced unintegrated retrogenes when
p611 was used in the envelope-producing packaging cells. Rather than
resulting from autoretrofection events, we think that these retrogenes
are episomes that may have resulted from viral budding into
intracellular compartments (9, 19) or from retrogenes formed
after extracellular reinfection that are blocked at integration. Since
these retrogenes were unintegrated, we cannot conclude that autoretrofection occurred when p611 was used as the reporter. Even
though retrofection of cellular RNAs lacking
sequences occurs
rather efficiently (18), blockage to superinfection or some
interference to integration by virus-producing cells might prevent
autoretrofection of such RNAs. The addition of the viral cis
elements in p
+611 allows detection of extracellular autoretrofection by allowing for a greater number of infectious virions containing the
reporter RNA.
 |
ACKNOWLEDGMENTS |
This work was supported by CA18282 from the NCI to M.L.L. R.L.
was supported by NIH NRSA CA09284 and a training grant from NCI (T32
CA09229). Support was provided by the FHCRC biotechnology and image
analysis facilities.
We appreciate the volunteer work of S. K. Luttio, a senior at Interlake
High School.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Division of
Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA
98104. Phone: (206) 667-4442. Fax: (206) 667-5939. E-mail:
mlinial{at}fhcrc.org.
 |
REFERENCES |
| 1.
|
Anderson, D. J.,
P. Lee,
K. L. Levine,
J. Sang,
S. A. Shah,
O. O. Yang,
P. R. Shank, and M. L. Linial.
1992.
Molecular cloning and characterization of the RNA packaging-defective avian retrovirus SE21Q1b.
J. Virol.
66:204-216[Abstract/Free Full Text].
|
| 2.
|
Anderson, D. J.,
J. Stone,
R. Lum, and M. L. Linial.
1995.
The packaging phenotype of SE21Q1b provirus is related to high proviral expression and not trans-acting factors.
J. Virol.
69:7319-7323[Abstract].
|
| 3.
|
Aronoff, R., and M. L. Linial.
1991.
Specificity of retroviral RNA packaging.
J. Virol.
65:71-80[Abstract/Free Full Text].
|
| 4.
|
Berg, D. E., and M. M. Howe.
1989.
In
Mobile DNA.
American Society for Microbiology, Washington, D.C.
|
| 5.
|
Craven, R. C.,
R. P. Bennett, and J. W. Wills.
1991.
Role of the avian retroviral protease in the activation of reverse transcriptase during virion assembly.
J. Virol.
65:6205-6217[Abstract/Free Full Text].
|
| 6.
|
Dickson, C.,
R. N. Eisenman,
H. Fan,
E. Hunter, and N. Teich.
1984.
Protein biosynthesis and assembly, p. 514-648.
In
R. Weiss, N. Teich, H. Varmus, and J. Coffin (ed.), RNA tumor viruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 7.
|
Dornburg, R., and H. M. Temin.
1990.
cDNA genes formed after infection with retroviral vector particles lack the hallmarks of natural processed pseudogenes.
Mol. Cell. Biol.
10:68-74[Abstract/Free Full Text].
|
| 8.
|
Dornburg, R., and H. M. Temin.
1990.
Presence of a retroviral encapsidation sequence in nonretroviral RNA increases the efficiency of formation of cDNA genes.
J. Virol.
64:886-889[Abstract/Free Full Text].
|
| 9.
|
Facke, M.,
A. Janetzo,
R. L. Shoeman, and H.-G. Krausslich.
1993.
A large deletion in the matrix domain of the human immunodeficiency virus gag gene redirects virus particle assembly from the plasma membrane to the endoplasmic reticulum.
J. Virol.
67:4972-4980[Abstract/Free Full Text].
|
| 10.
|
Garcia-Meunier, P.,
M. Etienne-Julan,
P. Fort,
M. Piechaczyk, and F. Bonhomme.
1993.
Concerted evolution in the GAPDH family of retrotransposed pseudogenes.
Mamm. Genome
4:695-703[Medline].
|
| 11.
|
Gorman, C.,
R. Padmanabhan, and B. H. Howard.
1983.
High efficiency DNA-mediated transformation of primate cells.
Science
221:551-553[Abstract/Free Full Text].
|
| 12.
|
Gritz, L., and J. Davies.
1983.
Plasmid-encoded hygromycin B resistance: the sequence of hygromycin B phosphotransferase gene and its expression in Escherichia coli and Saccharomyces cerevisiae.
Gene
25:179-188[Medline].
|
| 13.
|
Hajjar, A. M.
1995.
In
Retroviral recombination: insights from a model system. Ph.D. thesis.
University of Washington, Seattle.
|
| 14.
|
Heidmann, T.,
O. Heidmann, and J.-F. Nicolas.
1988.
An indicator gene to demonstrate intracellular transposition of defective retroviruses.
Proc. Natl. Acad. Sci. USA
85:2219-2223[Abstract/Free Full Text].
|
| 15.
|
Jurka, J.
1997.
Sequence patterns indicate an enzymatic involvement in integration of mammalian retroposons.
Proc. Natl. Acad. Sci. USA
94:1872-1877[Abstract/Free Full Text].
|
| 16.
|
Kaplan, A. H.,
M. Manchester, and R. Swanstrom.
1994.
The activity of the protease of human immunodeficiency virus type 1 is initiated at the membrane of infected cells before the release of viral proteins and is required for release to occur with maximal efficiency.
J. Virol.
68:6782-6786[Abstract/Free Full Text].
|
| 17.
|
Levine, K. L.,
B. Steiner,
K. Johnson,
R. Aronoff,
T. J. Quinton, and M. L. Linial.
1990.
Unusual features of integrated cDNAs generated by infection with genome-free retroviruses.
Mol. Cell. Biol.
10:1891-1900[Abstract/Free Full Text].
|
| 18.
|
Linial, M.
1987.
Creation of a processed pseudogene by retroviral infection.
Cell
49:93-102[Medline].
|
| 18a.
| Linial, M. Unpublished data.
|
| 19.
|
Lynch, W. P.,
W. J. Brown,
G. J. Spangrude, and J. L. Portis.
1994.
Microglial infection by a neurovirulent murine retrovirus results in defective processing of envelope protein and intracellular budding of virus particles.
J. Virol.
68:3401-3409[Abstract/Free Full Text].
|
| 20.
|
Maestre, J.,
T. Tchenio,
O. Dhellin, and T. Heidmann.
1995.
mRNA retroposition in human cells: processed pseudogene formation.
EMBO J.
14:6333-6338[Medline].
|
| 21.
|
Meng, A.
1994.
Simplified downward alkaline transfer of DNA.
BioTechniques
17:72-73.
[Medline] |
| 22.
|
Morgenstern, J. P., and H. Land.
1990.
Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line.
Nucleic Acids Res.
18:3587-3596[Abstract/Free Full Text].
|
| 23.
|
Petropoulos, C. J., and S. H. Hughes.
1991.
Replication-competent retrovirus vectors for the transfer and expression of gene cassettes in avian cells.
J. Virol.
65:3728-3737[Abstract/Free Full Text].
|
| 24.
|
Piatak, M., Jr.,
K.-C. Luk,
B. Williams, and J. D. Lifson.
1995.
Quantitative competitive polymerase chain reaction for accurate quantitation of HIV DNA and RNA species.
BioTechniques
14:70-81.
|
| 25.
|
Piechaczyk, M.,
J. M. Blanchard,
S. R.-E. Sabouty,
C. Dani,
L. Marty, and P. Jeanteur.
1984.
Unusual abundance of vertebrate 3-phosphate dehydrogenase pseudogenes.
Nature
312:469-471[Medline].
|
| 26.
|
Sober, H. A.
1970.
Nucleic acids, p. H-111.
In
R. C. Weast (ed.), Handbook of biochemistry. CRC Press, Cleveland, Ohio.
|
| 27.
|
Stewart, L.,
G. Schatz, and V. M. Vogt.
1990.
Properties of avian retrovirus particles defective in viral protease.
J. Virol.
64:5076-5092[Abstract/Free Full Text].
|
| 28.
|
Stewart, L., and V. M. Vogt.
1991.
trans-Acting viral protease is necessary and sufficient for activation of avian leukosis virus reverse transcriptase.
J. Virol.
65:6218-6231[Abstract/Free Full Text].
|
| 29.
|
Tanaka, A.,
H. Hara,
H. T. Park,
J. Wolfert,
M. Fujihara,
R. Izutani, and A. Kaji.
1992.
Infection of terminally differentiated myotubes with Rous sarcoma virus (RSV): lack of DNA integration but presence of RSV mRNA.
J. Gen. Virol.
73:1781-1790[Abstract/Free Full Text].
|
| 30.
|
Tchenio, T., and T. Heidmann.
1991.
Defective retroviruses can disperse in the human genome by intracellular transposition.
J. Virol.
65:2113-2118[Abstract/Free Full Text].
|
| 31.
|
Tchenio, T.,
E. Segal-Bendirdjian, and T. Heidmann.
1993.
Generation of processed pseudogenes in murine cells.
EMBO J.
12:1487-1497[Medline].
|
| 32.
|
Vogt, P. K.
1977.
Genetics of RNA tumor viruses, p. 341-455.
In
H. Fraenkel-Conrat, and R. R. Wagner (ed.), Comprehensive virology. Plenum Press, New York, N.Y.
|
| 33.
|
Vogt, P. K., and R. Ishizaki.
1965.
Reciprocal patterns of genetic resistance to avian tumor viruses in two lines of chickens.
Virology
26:664-672[Medline].
|
| 34.
|
Walsh, J. B.
1985.
How many processed pseudogenes are accumulated in a gene family?
Genetics
110:345-364[Abstract/Free Full Text].
|
| 35.
|
Weiner, A. M.,
P. L. Deininger, and A. Efstratiadis.
1986.
Nonviral retroposons: genes, pseudogenes, and transposable elements generated by the reverse flow of genetic information.
Annu. Rev. Biochem.
55:631-661[Medline].
|
| 36.
|
Weiss, R. A.
1984.
Experimental biology and assay of RNA tumor viruses, p. 209-260.
In
R. Weiss, N. Teich, H. Varmus, and J. Coffin (ed.), RNA tumor viruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 37.
|
Weller, S. K.,
A. E. Joy, and H. M. Temin.
1980.
Correlation between cell killing and massive second-round superinfection by members of some subgroups of avian leukosis virus.
J. Virol.
33:494-506[Abstract/Free Full Text].
|
J Virol, May 1998, p. 4057-4064, Vol. 72, No. 5
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
GILES, K. E., CAPUTI, M., BEEMON, K. L.
(2004). Packaging and reverse transcription of snRNAs by retroviruses may generate pseudogenes. RNA
10: 299-307
[Abstract]
[Full Text]